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Primary carcinosarcoma of the gallbladder
Sung Bae Park, Yang Hee Kim, Hye Lin Rho, Gi Bong Chae, Seong Kweon Hong
Department of Surgery, Kangwon National University Hospital, Chuncheon, Korea
Carcinosarcoma of gallbladder (CSGB) is a rare malignancy characterized by malignant epithelial and mesenchymal 
components. Its pathogenesis is unknown and most CSGBs are associated with poor survival because the disease normally 
presents at an advanced stage, and as a result, curative resection is uncommon. This report describes a case that underwent 
curative resection. A 77-year-old woman presented with right upper quadrant pain. The preoperative diagnosis was gall-
bladder (GB) cancer, and thus, curative radical cholecystectomy was performed. However, pathologic examination of the 
surgical specimen revealed that the tumor was composed of two histologic components of squamous cell carcinoma and 
spindle cell sarcoma, which was consistent with a diagnosis of carcinosarcoma. The tumor was found to extend to the peri-
muscular connective tissue and to have metastasized to one lymph node (LN). The prognosis of CSGB remains poor despite 
curative resection, and thus, the authors recommend that effort be made to improve surgical outcomes.
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INTRODUCTION
The vast majority of gallbladder (GB) cancers are ad-
enocarcinomas with carcinosarcomas accounting for few-
er than 1% of GB cancers. Carcinosarcoma is characterized 
by malignant epithelial and mesenchymal elements, and 
has been reported in many different organs, including the 
uterus, lung, esophagus, kidney, and pancreas [1]. The 
prognosis of patients with carcinosarcoma of the gall-
bladder (CSGB) has been reported to be poor [2]. Accor-
dingly, in most cases curative resection is not possible. The 
invasive nature and aggressive biology of CSGB ad-
equately explains the limited number of resectabxle cases. 
Here, we report a case of CSGB treated by curative radical 
cholecystectomy.
CASE REPORT
A 77-year-old woman was admitted via our emergency 
department due to a complaint of severe right upper quad-
rant (RUQ) abdominal pain of one day’s duration. Her 
medical history revealed that she was undergoing treat-
ment for unstable angina. A physical examination re-
vealed a woman in acute distress. Her blood pressure was 
150/70 mmHg yet other vital signs were stable. She had no 
abnormal finding on chest examination. She had mild ten-
derness in the RUQ, but no rebound tenderness or muscle Primary carcinosarcoma of the gallbladder
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Fig. 1. Abdomen computed tomography showed diffuse distension 
of gallbladder (GB) with irregular intraluminal polypoid masses - 
possible GB cancer rather than xanthogranulomatous cholecystitis.
guarding. She was negative for Murphy’s sign. Laboratory 
findings showed a white blood cell count of 17,000/mm
3 
(seg; 88%), hemoglobin 10.0 g/dL, C-reactive protein 6.418 
mg/dL, serum albumin 2.9 g/dL, aspartate aminotrans-
ferase 253 U/L, and alanine aminotransferase 58 U/L. 
Other laboratory test results, including electrolyte and uri-
nalysis findings, were within normal limits. A tumor mar-
ker examination revealed that alpha-fetoprotein (αFP) 
and carcinoembryonic antigen (CEA) were within the nor-
mal range, but that carbohydrate antigen 19-9 (CA19-9) 
and cancer antigen 125 (CA125) were mildly elevated 
(CA19-9 42.6 U/mL and CA125 42.1 U/mL). Chest and ab-
dominal radiographs, electrocardiography, and echocar-
diography failed to depict any significant abnormality. 
However, abdominal computed tomography (CT) show-
ed diffuse GB distension and an irregular intraluminal 
polypoid mass with no demonstrable lymph nodes (LNs) 
in the pericholecystic and upper abdominal regions (Fig. 
1). These radiologic findings suggested GB cancer and, 
thus, we diagnosed GB cancer and scheduled surgery. At 
laparotomy, the GB was found to be enlarged to about 6 × 
10 cm and to have a thick wall. There was no evidence of 
distant metastasis. The patient underwent cholecystec-
tomy, which included resection of 3 to 5 cm wedge of liver 
tissue at the gallbladder bed, and combined LN dissection. 
Frozen section examination indicated that all resection 
margins were cancer cell free.
The postoperative specimen showed a tumor size of 7.8 
× 5.5 × 1.2 cm, and histologically, the tumor was found to 
contain distinct regions of squamous cell carcinoma and 
high-grade spindle cell sarcoma (Fig. 2). Furthermore, the 
tumor was found to have extended to perimuscular con-
nective tissue and to have metastasized to one of the 14 
LNs excised. The stage of patient was classified as type IIIB 
(T2N1M0) using the classification of the American Joint 
Committee on Cancer (AJCC). Final diagnosis was made 
based on immunohistochemical findings, that is, squa-
mous carcinoma components were stained by cytokeratin 
but not by vimentin, and conversely, sarcoma components 
were stained by vimentin but not by cytokeratin (Fig. 3). 
Her postoperative course was uncomplicated and she 
was discharged 14 days postoperatively. The patient and 
her family refused postoperative adjuvant chemotherapy 
and radiation therapy. At 1 month postoperative, abdomi-
nal CT revealed no cancer recurrence, but at 70 days post-
operative, she revisited our hospital complaining of nau-
sea, vomiting, indigestion, melena, and general weakness. 
Abdominal CT performed at the time showed a huge 
metastatic mass involving S4 of the liver, the 1st portion of 
the duodenum, and multiple, variably sized, cancerous 
masses with central necrosis in the dependant portion of 
the abdominal cavity (Fig. 4). Conservative treatment was 
initiated but she died a few days later.
DISCUSSION
GB cancers account for 1 to 2% of all cancers. Adenocar-
cinoma accounts for the majority of primary malignant ne-
oplasms of the GB, and squamous cell carcinoma, undiffe-
rentiated carcinoma, tumors with choriocarcinoma-like 
differentiation, and sarcoma account for the remainder 
[1]. CSGBs are rare and constitute less than 1% of GB 
cancers. The symptoms of CSGB are non-specific. The pre-
operative diagnosis of CSGB is difficult because imaging 
studies, such as, ultrasonography, CT, and abdominal an-
giography cannot differentiate it from carcinoma of the 
GB. Tumor markers such as αFP, CEA, CA19-9 and CA125 
are also non-specific [2,3]. Carcinosarcomas are character-
ized by malignant epithelial and mesenchymal compo-Sung Bae Park, et al.
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Fig. 2. Microscopic finding. (A) Well differentiated squamous cell carcinoma components (H&E, ×200). (B) High-grade spindle cell sarcoma 
components (H&E, ×400).
Fig. 3. Immunohistochemical stain. (A) Strong cytokeratin positivity in malignant glands forming the epithelial component (Cytokeratin, 
×200). (B) Strong vimentin positivity in the sarcoma component (Vimentin, ×200).
nents. The most common epithelial component is ad-
enocarcinoma, but a squamous cell carcinoma component 
is also frequently present. Furthermore, squamous cell 
carcinoma is known to grow at twice the speed of ad-
enocarcinomas and to have a poorer prognosis [4]. The 
most frequent mesenchymal component is spindle cell 
sarcoma, followed by bone, cartilage, and other mesen-
chymal tissues [2]. Due to their rarity, the histogenesis and 
natural history of carcinosarcoma is uncertain. They are 
generally classified into two groups, namely, “true carci-
nosarcomas” and “so-called carcinosarcomas. True carci-
nosarcomas, in which a carcinoma and sarcoma arise si-
multaneously, exhibit apparent sarcomatous differentia-
tion toward specific tissues, such as, osteoid, cartilage, or 
striated muscle, whereas so-called carcinosarcomas, in 
which a sarcomatous reaction occurs in a carcinoma, ex-
hibit epithelial differentiation in a sarcomatoid compo-
nent, and are termed sarcomatoid or spindle cell carcino-Primary carcinosarcoma of the gallbladder
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Fig. 4. Abdomen computed tomography showed huge metastatic mass involving liver S4 (A), and duodenum 1st portion (B). Multiple 
variable sized masses with central necrosis in the dependant portion of the abdominal cavity (C).
mas [5]. The diagnosis of CSGB must be confirmed by mi-
croscopic findings and immunohistochemical staining. 
Microscopically, the diagnosis of CSGB requires the pres-
ence of both malignant epithelial and mesenchymal ele-
ments, though these may be intimately admixed and show 
characteristics intermediate between the two cell types. By 
immunohistochemistry, the carcinomatous component is 
positive for epithelial markers, such as, cytokeratin and 
epithelial membrane antigen (EMA), and the sarcomatoid 
component is positive for mesenchymal markers like vi-
mentin, desmin and actin.
In CSGB, the sarcomatoid component is negative for ep-
ithelial markers, such as, cytokeratin, EMA, whereas sar-
comatoid carcinoma is positive for epithelial markers, 
such as, cytokeratin and EMA [5,6]. In our case, the tumor 
was composed of squamous cell carcinoma and spindle 
cell sarcoma, and the squamous cell carcinoma compo-
nent was positive for cytokeratin and negative for vi-
mentin, whereas the spindle cell sarcoma component was 
negative for cytokeratin and positive for vimentin. 
Therapeutic interventions have not been well defined 
and no optimal postoperative adjuvant therapy, such as, 
chemotherapy and radiation therapy, has been established 
because of the rarity of CSGB and its poor prognosis. 
CSGB is treated in the same way as other gallbladder 
cancers. Accordingly, the best treatment option is surgical 
excision. Cholecystectomy alone is sufficient for cancer 
cells confined to the lamina propria, whereas more ad-
vanced states require resection of a 3 to 5 cm wedge of liver 
tissue at the gallbladder bed, combined with LN dis-
section in the absence of evidence of distant metastasis. 
More extensive procedures, such as, right hepatectomy, 
probably increase risk and confer no survival benefit [2-5]. 
In our case, there was no evidence of distant metastasis or 
of invasion of adjacent organs, and we performed curative 
radical cholecystectomy. 
The prognosis of CSGB patients has been reported to be 
poor. In many patients at presentation, tumors are large 
and nodular and invade peripheral organs. Mean survival 
after diagnosis is only a few months in such cases. The 
overall 5-year survival rate after surgery is 31.0%. [3] Two 
factors importantly predict a good prognosis; curative re-
section and early stage (stage I or stage II) disease, accord-
ing to the AJCC classification. The 5-year survival rate af-
ter curative resection for CSGB is 88.9% when invasion is 
restricted to the muscularis propria [2,4,6,7]. CSGB may 
recur as liver metastasis, peritoneal dissemination, or as 
LN metastasis. 
The majority of recurrences occur within half a year of 
surgery and for those that succumb to the disease, median 
time to recurrence is 50 days. Postoperative adjuvant che-
motherapy options for CSGB are not well defined. Previ-
ous studies have reported the use of chemoradiotherapy 
after surgical resection, but this treatment conferred no 
clear advantage [8,9]. In our patient, despite curative re-
section, the prognosis was expected to be poor due to the 
presence of the squamous cell carcinoma component and 
a IIIB postoperative pathologic stage. 
CSGB is a rare tumor, characterized by both malignant 
epithelial and mesenchymal components with a poorer 
prognosis than ordinary gallbladder adenocarcinoma. If 
curative resection is performed in stage I or II, a good Sung Bae Park, et al.
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prognosis is possible. More clinicopathological data and 
further studies are required to identify the prognostic in-
dicators and the histogenesis of gallbladder carcinosar-
coma.
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